Results 281 to 290 of about 16,195 (312)
Some of the next articles are maybe not open access.
Inhaled Dry Powder Formulations for Treating Tuberculosis
Current Drug Delivery, 2015Tuberculosis is the second leading cause of death from infectious diseases. Although antitubercular drugs have been traditionally administered orally, there is a growing interest in delivering drugs via the pulmonary route using nebulisers or dry powder inhalers.
Shyamal, Das +2 more
openaire +2 more sources
[Easyhaler--ideal dry powder inhaler].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2010Dry powder inhalers (DPI) differ among each other in many technical aspects, size and value of lung deposition as well as clinical efficacy of inhaled drugs. Easyhaler is a reservoir, multi-dose, high-resistance DPI and it is easy to operate. The device needs low inspiratory flows which are possible to achieve even by asthmatic children over 5-year-old
Emeryk, Andrzej +1 more
openaire +1 more source
Dry Powder Inhalers (DPI): A Comprehensive Review Article on Dry Powder Inhaler (DPI)
In the treatment of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), dry powder inhalers (DPIs) have emerged as a crucial substitute for pressurized metered-dose inhalers (pMDIs). The desire for more effective and user-friendly drug delivery systems, as well as environmental concerns about the chlorofluorocarbon (CFC)openaire +1 more source
Dry powder inhalers: an overview.
Respiratory care, 2005Dry powder inhalers (DPIs) are a widely accepted inhaled delivery dosage form, particularly in Europe, where they currently are used by a large number of patients for the delivery of medications to treat asthma and chronic obstructive pulmonary disease.
openaire +1 more source
Physical stability of dry powder inhaler formulations
Expert Opinion on Drug Delivery, 2020Nivedita Shetty +2 more
exaly